Quest Diagnostics (DGX) Profit After Tax Growth (3y) (2012 - 2026)
Quest Diagnostics (DGX) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 8.53% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -1.85% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | -4.58% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 13.70% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 6.28% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.28% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 9.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.28% |
| Mar 31, 2026 | 6.75% |
| Dec 31, 2025 | 30.19% |
| Sep 30, 2025 | -2.10% |
| Jun 30, 2025 | 5.79% |
| Mar 31, 2025 | -14.27% |
| Dec 31, 2024 | -17.02% |
| Sep 30, 2024 | -23.39% |
| Jun 30, 2024 | -28.26% |
| Mar 31, 2024 | -24.85% |
| Dec 31, 2023 | -30.44% |
| Sep 30, 2023 | -26.26% |
| Jun 30, 2023 | 8.86% |
| Mar 31, 2023 | 26.97% |
| Dec 31, 2022 | -24.07% |
| Sep 30, 2022 | 6.89% |
| Jun 30, 2022 | 1.51% |
| Mar 31, 2022 | 28.45% |
| Dec 31, 2021 | 43.76% |
| Sep 30, 2021 | 32.41% |